| Product Code: ETC6081337 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Psychedelic Drugs Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Psychedelic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Psychedelic Drugs Market - Industry Life Cycle |
3.4 Andorra Psychedelic Drugs Market - Porter's Five Forces |
3.5 Andorra Psychedelic Drugs Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Andorra Psychedelic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Andorra Psychedelic Drugs Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Andorra Psychedelic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Andorra Psychedelic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Andorra Psychedelic Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Andorra Psychedelic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance and legalization of psychedelic drugs for therapeutic purposes |
4.2.2 Growing interest in alternative and natural treatments for mental health disorders |
4.2.3 Rising awareness about the potential benefits of psychedelic drugs in treating various health conditions |
4.3 Market Restraints |
4.3.1 Stringent regulations and legal restrictions on the use and distribution of psychedelic drugs |
4.3.2 Limited availability of research and clinical data supporting the efficacy and safety of psychedelic drugs |
4.3.3 Stigma and societal perceptions surrounding the use of psychedelic drugs |
5 Andorra Psychedelic Drugs Market Trends |
6 Andorra Psychedelic Drugs Market, By Types |
6.1 Andorra Psychedelic Drugs Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Andorra Psychedelic Drugs Market Revenues & Volume, By Source, 2021- 2031F |
6.1.3 Andorra Psychedelic Drugs Market Revenues & Volume, By Synthetic, 2021- 2031F |
6.1.4 Andorra Psychedelic Drugs Market Revenues & Volume, By Natural, 2021- 2031F |
6.2 Andorra Psychedelic Drugs Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Andorra Psychedelic Drugs Market Revenues & Volume, By Empathogens, 2021- 2031F |
6.2.3 Andorra Psychedelic Drugs Market Revenues & Volume, By Dissociatives, 2021- 2031F |
6.3 Andorra Psychedelic Drugs Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Andorra Psychedelic Drugs Market Revenues & Volume, By Gamma-Hydroxybutyric Acid, 2021- 2031F |
6.3.3 Andorra Psychedelic Drugs Market Revenues & Volume, By Ketamine, 2021- 2031F |
6.3.4 Andorra Psychedelic Drugs Market Revenues & Volume, By Psilocybin, 2021- 2031F |
6.4 Andorra Psychedelic Drugs Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Andorra Psychedelic Drugs Market Revenues & Volume, By Treatment Resistant Depression, 2021- 2031F |
6.4.3 Andorra Psychedelic Drugs Market Revenues & Volume, By Major Depressive Disorder, 2021- 2031F |
6.4.4 Andorra Psychedelic Drugs Market Revenues & Volume, By Opiate Addiction, 2021- 2031F |
6.4.5 Andorra Psychedelic Drugs Market Revenues & Volume, By Post-Traumatic Stress Disorder, 2021- 2031F |
6.5 Andorra Psychedelic Drugs Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Andorra Psychedelic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Andorra Psychedelic Drugs Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.5.4 Andorra Psychedelic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.6 Andorra Psychedelic Drugs Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Andorra Psychedelic Drugs Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.3 Andorra Psychedelic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Andorra Psychedelic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
7 Andorra Psychedelic Drugs Market Import-Export Trade Statistics |
7.1 Andorra Psychedelic Drugs Market Export to Major Countries |
7.2 Andorra Psychedelic Drugs Market Imports from Major Countries |
8 Andorra Psychedelic Drugs Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on psychedelic drugs in Andorra |
8.2 Adoption rates of psychedelic-assisted therapy programs in healthcare facilities |
8.3 Public perception and attitude surveys towards psychedelic drug use in Andorra |
9 Andorra Psychedelic Drugs Market - Opportunity Assessment |
9.1 Andorra Psychedelic Drugs Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Andorra Psychedelic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Andorra Psychedelic Drugs Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Andorra Psychedelic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Andorra Psychedelic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Andorra Psychedelic Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Andorra Psychedelic Drugs Market - Competitive Landscape |
10.1 Andorra Psychedelic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Andorra Psychedelic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here